Literature DB >> 11866308

Pioglitazone-associated fulminant hepatic failure.

Michael P Chase, Joseph C Yarze.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866308     DOI: 10.1111/j.1572-0241.2002.05516.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  11 in total

1.  Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis.

Authors:  Susumu Itoh; Azuma Kanazuka; Takahide Akimoto
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Fatal liver failure associated with pioglitazone.

Authors:  Ed Farley-Hills; R Sivasankar; M Martin
Journal:  BMJ       Date:  2004-08-21

Review 3.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

Review 4.  Pioglitazone: a review of its use in type 2 diabetes mellitus.

Authors:  John Waugh; Gillian M Keating; Greg L Plosker; Stephanie Easthope; Dean M Robinson
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Prediction of drug-induced liver injury using keratinocytes.

Authors:  Rika Hirashima; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  J Appl Toxicol       Date:  2017-01-31       Impact factor: 3.446

6.  Drug-induced Liver Injury.

Authors:  Stefan David; James P Hamilton
Journal:  US Gastroenterol Hepatol Rev       Date:  2010-01-01

7.  Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.

Authors:  Shuji Sumie; Takumi Kawaguchi; Atsushi Kawaguchi; Ryoko Kuromatsu; Masahito Nakano; Manabu Satani; Shingo Yamada; Shusuke Okamura; Yuko Yonezawa; Tatsuyuki Kakuma; Takuji Torimura; Michio Sata
Journal:  Mol Clin Oncol       Date:  2014-10-06

8.  Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone.

Authors:  N L Julie; I M Julie; A I Kende; G L Wilson
Journal:  Diabetologia       Date:  2008-08-23       Impact factor: 10.122

9.  Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.

Authors:  Rachna Kasliwal; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Toxicological evaluation of subchronic use of pioglitazone in mice.

Authors:  Said Said Elshama; Ayman El-Meghawry El-Kenawy; Hosam-Eldin Hussein Osman
Journal:  Iran J Basic Med Sci       Date:  2016-07       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.